Hillsdale Investment Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-322,200
| Closed | -$6.39M | – | 615 |
|
|
2025
Q1 | $6.39M | Sell |
322,200
-1,500
| -0.5% | -$29.8K | 0.33% | 44 |
|
|
2024
Q4 | $5.55M | Sell |
323,700
-13,650
| -4% | -$234K | 0.28% | 66 |
|
|
2024
Q3 | $6.74M | Sell |
337,350
-229,580
| -40% | -$4.59M | 0.52% | 31 |
|
|
2024
Q2 | $6.34M | Sell |
566,930
-62,970
| -10% | -$704K | 0.5% | 34 |
|
|
2024
Q1 | $4.16M | Buy |
629,900
+628,400
| +41,893% | +$4.15M | 0.33% | 114 |
|
|
2023
Q4 | $6.78K | Buy |
1,500
+100
| +7% | +$452 | ﹤0.01% | 477 |
|
|
2023
Q3 | $5.01K | Buy |
1,400
+420
| +43% | +$1.5K | ﹤0.01% | 515 |
|
|
2023
Q2 | $3.62K | Sell |
980
-204,720
| -100% | -$755K | ﹤0.01% | 490 |
|
|
2023
Q1 | $681K | Buy |
+205,700
| New | +$681K | 0.06% | 246 |
|